Calgon rebranding
This article was originally published in The Rose Sheet
Executive Summary
Ilex Capital Group's Calgon line is targeted for a "total rebranding effort" beginning in March. Best known for its "Calgon, take me away" tagline, the rebrand will include new packaging, logo, product extensions and marketing campaign. "The rebranding reinforces a strong brand heritage in the bath category with fresh imagery to help consumers rediscover an active, sensual Calgon experience," firm says Dec. 18. New packaging designs will feature "vivid colors, bold imagery and sensual landscapes" and the new logo will feature a script-style font and replace the "o" in Calgon with a botanical flower to promote a "more vibrant message of confidence and escape," according to the firm. More than 30 new products will be introduced with the re-launch, including mineral salts, Epsom salts, bubble baths and bath fizzy sets, as well as new fragrances and formulas for signature products
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.